β-Adrenergic Receptor Stimulation Maintains NCX-CaMKII Axis and Prevents Overactivation of IL6R-Signaling in

Ingrid Matzer1, Julia Voglhuber1,2, Mara Kiessling1

  • 1Department of Cardiology, Medical University of Graz, 8036 Graz, Austria.

Biomedicines
|July 27, 2022
PubMed

Insights

Excessive beta-adrenergic stimulation and tachycardia can harm the heart. This study reveals beta-adrenergic signaling protects against interleukin-6 receptor (IL6R) overactivation during increased workload, a finding crucial for heart disease therapies.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Cellular Physiology

Background:

  • Excessive beta-adrenergic stimulation and tachycardia are known triggers of cardiac remodeling.
  • The precise cellular mechanisms underlying these effects on cardiomyocyte gene expression are not fully understood.

Purpose of the Study:

  • To investigate the impact of beta-adrenergic stimulation and tachycardia on cardiomyocyte gene expression profiles.
  • To elucidate the role of sodium-calcium exchanger (NCX) and calcium/calmodulin-dependent kinase II (CaMKII) in cardiac remodeling.
  • To explore the protective function of beta-adrenergic signaling in preventing cardiac pathology.

Main Methods:

  • Utilized neonatal rat ventricular cardiomyocytes and hypertensive Dahl salt-sensitive rats.
  • Assessed gene expression, including interleukin-6 receptor (IL6R).
  • Employed pharmacological interventions: isoprenaline, propranolol, and an NCX inhibitor (ORM-10962).

Main Results:

  • Tachycardia upregulated sodium-calcium exchanger (NCX) and activated nuclear calcium/calmodulin-dependent kinase II (CaMKII).
  • Isoprenaline ameliorated NCX upregulation and modulated CaMKII activity.
  • Tachycardia induced interleukin-6 receptor (IL6R) upregulation, which was prevented by isoprenaline but required simultaneous CaMKII activation and NCX inhibition.
  • Blunted beta-adrenergic signaling in hypertensive rats correlated with NCX upregulation and enhanced IL6R signaling.

Conclusions:

  • Beta-adrenergic signaling plays a protective role by preventing interleukin-6 receptor (IL6R) overactivation under increased cardiac workload.
  • This protective mechanism is compromised in cardiac pathologies.
  • Understanding these pathways can inform therapeutic strategies, particularly for patients on beta-blockers.

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.8K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.9K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.6K
Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
2.9K
Sympathetic Signaling01:31

Sympathetic Signaling

Sympathetic signaling, a vital part of the autonomic nervous system, plays a crucial role in mobilizing the body's resources in response to stress or emergencies. It involves the transmission of nerve impulses from sympathetic preganglionic fibers to postganglionic fibers. This results in the release of specific neurotransmitters and activation of adrenergic receptors.
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
1.2K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
4.8K